Alerts will be sent to your verified email
Verify Email
LALPATHLAB
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Dr. Lal Pathlabs Limited is a leading provider of diagnostic and related healthcare tests and services in India, offering a comprehensive range of services to individual patients, hospitals, healthcare providers, and corporate customers.
Dr. Lal Pathlabs major competitors are Vijaya Diagnostic, Metropolis Health., Thyrocare Tech., Vimta Labs, Krsnaa Diagnostics, Nidan Labs. & Health, Cupid.
Market Cap of Dr. Lal Pathlabs is ₹25,350 Crs.
While the median market cap of its peers are ₹6,537 Crs.
Dr. Lal Pathlabs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jul Oct | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | |||||||
| Investor Presentation | Apr Jul Oct | Mar Jun Sep Dec | Mar Jun Aug Sep Dec | Feb Mar May Jun Jul Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | |||||||
| Conference Call | Mar Aug Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | |||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
